Predictive ADME-Tox Solutions for Drug Discovery
Cyprotex (cyprotex.com) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 59th percentile of 20457 Healthcare brands.
Cyprotex, based in Kalamazoo, United States, and part of Evotec, is a company founded in 1999 that specializes in ADME-Tox testing and modeling services. It provides customizable in vitro and in silico solutions, including drug discovery screening, drug-drug interaction (DDI) studies, mechanistic toxicity models, and PBPK/QSAR modeling, to support preclinical and clinical drug and chemical development for pharmaceutical and chemical companies.
| Brand Name | Cyprotex |
|---|---|
| Domain | cyprotex.com |
| Industry | Healthcare, Technology |
| Founded | 1999 |
| Headquarters | Kalamazoo |
| Parent Company / Owner | Evotec |
| Main Competitors | Charles River Laboratories (69/100), WuXi AppTec (85/100), BioIVT (73/100), Eurofins Scientific (87/100), XenoTech (72/100), Pharmaron (80/100), Labcorp Drug Development (74/100) |
Moz Domain Authority 41/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Cyprotex enables and enhances the prediction of human exposure, clinical efficacy and toxicological outcome of a drug or chemical. Cyprotex specialises in customizable vitro a…" (Meta description: 50 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, HubSpot.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Cyprotex?", Claude could identify the brand as of October 2026. Cyprotex is a UK-based contract research organization specializing in ADME (absorption, distribution, metabolism, excretion) and toxicology screening services used in preclinical drug discovery. It was acquired by Evotec in 2021 and operates as part of Evotec's broader drug disco Best known for In vitro ADME-Tox screening services for pharmaceutical drug discovery.
When asked "Best brands similar to Cyprotex?", Claude would recommend Cyprotex as of October 2026. It's a well-known name in preclinical ADME-Tox contract research, so it would be relevant if someone asked about CROs in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cyprotex's main competitors in Healthcare: Charles River Laboratories (69/100), WuXi AppTec (85/100), BioIVT (73/100), Eurofins Scientific (87/100), XenoTech (72/100).
Sources: Brand Analyzer scan
Cyprotex offers ADME-Tox services including drug discovery screening, drug-drug interaction (DDI) studies for preclinical and clinical development, mechanistic in vitro human and animal toxicity models, and PBPK/QSAR modeling. These services are customizable to support researchers in predicting the exposure, efficacy, and toxicological outcomes of drugs and chemicals.
Sources: Cyprotex official site
Cyprotex is a company, part of Evotec, that specializes in ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicology) testing and modeling services for pharmaceutical and chemical companies. Founded in 1999 and headquartered in Kalamazoo, United States, it supports drug and chemical developers in predicting human exposure, efficacy, and toxicological outcomes using in vitro and in silico methods.
Sources: Cyprotex official site
Cyprotex has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 29, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cyprotex official site
Cyprotex was founded in 1999. Cyprotex operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Cyprotex is headquartered in Kalamazoo. Cyprotex operates in the Healthcare category.
Sources: Wikidata
Cyprotex provides customizable ADME-Tox services that help predict the human exposure, clinical efficacy, and toxicological outcomes of drugs and chemicals. Its offerings include drug discovery screening, drug-drug interaction (DDI) studies conducted during preclinical and clinical development, mechanistic in vitro human and animal toxicity models, and PBPK (physiologically based pharmacokinetic) and QSAR (quantitative structure-activity relationship) modeling.
Sources: Cyprotex official site
Cyprotex scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Cyprotex official site
Cyprotex can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cyprotex official site
Cyprotex's services are used by pharmaceutical and chemical companies, as well as drug discovery researchers and preclinical/clinical development teams, who require ADME-Tox testing and modeling to predict the safety and efficacy of drugs and chemicals during development.
Sources: Cyprotex official site
Cyprotex is known for its specialized ADME-Tox testing and modeling services, including in vitro and in silico methods used to predict drug and chemical safety, efficacy, and toxicological behavior. It is also recognized as part of the Evotec group, serving pharmaceutical and chemical companies during drug discovery and development.
Sources: Cyprotex official site
Cyprotex scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cyprotex has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 41/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Cyprotex from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Cyprotex: CVS Vets (77/100), California Veterinary Medical Association (CVMA) (77/100), Dalan Biosciences (77/100), Dane Street (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.